01 1Afinitor
02 9Afinitor/Votubia
03 1Everolimus Stent Drug
04 2Everolimus stent drug
05 1Zortress
06 8Zortress/Certican
Main Therapeutic Indication : Immunology
Currency : USD
2020 Revenue in Millions : 452
2019 Revenue in Millions : 485
Growth (%) : -7
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 1,083
2019 Revenue in Millions : 1,539
Growth (%) : -30
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 938
2020 Revenue in Millions : 1,083
Growth (%) : -13
Main Therapeutic Indication : Immunology
Currency : USD
2021 Revenue in Millions : 431
2020 Revenue in Millions : 452
Growth (%) : -5
Main Therapeutic Indication : Immunology
Currency : USD
2022 Revenue in Millions : 329
2021 Revenue in Millions : 431
Growth (%) : -24
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 512
2021 Revenue in Millions : 938
Growth (%) : -45
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 408
2022 Revenue in Millions : 512
Growth (%) : -20
Main Therapeutic Indication : Oncology
Currency : USD
2014 Revenue in Millions : 20.30%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...
Currency : USD
2014 Revenue in Millions : 31.30%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...
Currency : USD
2014 Revenue in Millions : -17.00%
2013 Revenue in Millions :
Growth (%) :
LOOKING FOR A SUPPLIER?